Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study.
Daniel
V
V
Department of Transplantation Immunology, University of Heidelberg, Germany.
Pasker
S
S
Reiss
U
U
Weimer
R
R
Wiesel
M
M
Pomer
S
S
Staehler
G
G
Opelz
G
G
D015415:Biomarkers / Q000097:blood; D003141:Communicable Diseases / Q000175:diagnosis* / Q000209:etiology; D016207:Cytokines / Q000097:blood*; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D006084:Graft Rejection / Q000175:diagnosis*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood*; D006801:Humans; D007377:Interleukin-3 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008991:Monitoring, Physiologic; D011956:Receptors, Cell Surface / Q000032:analysis; D012189:Retrospective Studies
D015415:Biomarkers; D016207:Cytokines; D007377:Interleukin-3; D015850:Interleukin-6; D011956:Receptors, Cell Surface; D016178:Granulocyte-Macrophage Colony-Stimulating Factor